Avenue Therapeutics, Inc. Stock
Stocks
ATXI
US05360L4032
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
22:11:18 12/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.2800 USD | -8.29% |
|
-34.72% | -58.84% |
| Market Cap | 923K 836K 773K 698K 1.31M 86.99M 1.36M 9.29M 3.68M 46.47M 3.46M 3.39M 148M | P/E 2024 |
-0.22x | P/E 2025 | -0.73x |
|---|---|---|---|---|---|
| Enterprise Value | -1.93M -1.75M -1.62M -1.46M -2.75M -182M -2.85M -19.46M -7.72M -97.33M -7.25M -7.1M -309M | EV / Sales 2024 |
-
| EV / Sales 2025 | -491,128x |
| Free-Float |
86.49% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -8.29% | ||
| 1 week | -34.72% | ||
| Current month | -34.56% | ||
| 1 month | -33.33% | ||
| 3 months | -0.23% | ||
| 6 months | -30.26% | ||
| Current year | -58.84% |
| 1 week | 0.28 |  | 0.43 |
| 1 month | 0.28 | | 0.43 |
| Current year | 0.15 | | 0.9 |
| 1 year | 0.15 | | 0.96 |
| 3 years | 0.15 | | 26.47 |
| 5 years | 0.15 | | 2,013.75 |
| 10 years | 0.15 | | 13,882.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 59 | 01/08/2022 | |
David Jin
CEO | Chief Executive Officer | 36 | 31/03/2022 |
Jaclyn Jaffe
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 09/02/2015 | |
Neil Herskowitz
BRD | Director/Board Member | 69 | 01/08/2015 |
Jay Kranzler
CHM | Chairman | 68 | 07/03/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/01/26 | Free | Company | 111,209 | 3.4934% | ||
| 31/03/25 | Free | Company | 33,724 | 1.6419% | ||
| 31/12/24 | Other | Company | 294,800 | 15.4214% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.29% | -34.72% | -63.16% | -98.11% | 923K | |
| -2.69% | -0.48% | +51.67% | +69.09% | 66.33B | |
| -0.92% | +7.67% | +14.26% | +90.92% | 60.62B | |
| 0.00% | +0.39% | +20.52% | +98.45% | 55.5B | |
| +0.14% | +2.35% | +13.08% | +109.47% | 47.58B | |
| -2.21% | -2.47% | +18.60% | +36.89% | 43.69B | |
| -2.30% | -10.40% | +167.61% | +776.79% | 37.27B | |
| +2.15% | +1.42% | +15.17% | +56.49% | 36.57B | |
| -2.32% | -2.24% | +75.52% | +52.70% | 32.22B | |
| +2.62% | +5.90% | -36.55% | +406.95% | 26.58B | |
| Average | -1.38% | +0.04% | +27.67% | +159.96% | 41B | |
| Weighted average by Cap. | -0.83% | +0.20% | +37.23% | +162.19% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 1.4 1.27 1.18 1.06 2 132.38 2.07 14.14 5.61 70.71 5.27 5.16 224.47 |
| Net income | -11.65M -10.56M -9.77M -8.81M -16.61M -1.1B -17.19M -117M -46.52M -587M -43.73M -42.8M -1.86B | -2.91M -2.64M -2.44M -2.2M -4.15M -274M -4.29M -29.29M -11.61M -147M -10.92M -10.69M -465M |
| Net Debt | -2.59M -2.35M -2.17M -1.96M -3.7M -245M -3.83M -26.12M -10.36M -131M -9.73M -9.53M -415M | -2.86M -2.59M -2.39M -2.16M -4.07M -269M -4.21M -28.75M -11.4M -144M -10.71M -10.49M -456M |
Employees
1
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/11/26 | $0.2800 | -8.29% | 2,828 |
| 09/11/26 | $0.3053 | -28.81% | 1,129 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATXI Stock
Select your edition
All financial news and data tailored to specific country editions
